Advertisements


We are Sorry, This Page doesn't Exist


Technical Take: Spectrum rallies on Anerson"s Phase 2 data of poziotinib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 10th, 2018

Reata Pharmaceuticals initiates phase 1 trial of RTA 1701

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 49 min. ago

Amgen Drug Receives Approval

The approval for the drug used to treat a rare form of leukemia is based on overall survival data from the Phase 3 TOWER studyRelated Stocks: AMGN,.....»»

Category: blogSource: gurufocus6 hr. 34 min. ago

Starbucks CEO sees transitioning to "growth at scale" phase

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall9 hr. 19 min. ago

Agios (AGIO) Initiates Phase III Study on PK Deficiency Drug

Zacks.....»»

Category: topSource: redinews9 hr. 49 min. ago

Atossa completes all dosing, clinical visits in topical Endoxifen Phase 1 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall10 hr. 4 min. ago

Your Daily Pharma Scoop: TG Therapeutics Phase 2 Results, Geron Positive, Agio In Phase 3

Your Daily Pharma Scoop: TG Therapeutics Phase 2 Results, Geron Positive, Agio In Phase 3.....»»

Category: topSource: seekingalpha10 hr. 19 min. ago

Histogenics Phase 3 study likely to succeed, says H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall10 hr. 49 min. ago

Agios (AGIO) Initiates Phase III Study on PK Deficiency Drug

Agios Pharmaceuticals, Inc. (AGIO), initiates a phase III ACTIVATE study which will evaluateits lead rare genetic diseases candidate, AG-348 in patients with PK deficiency w.....»»

Category: dealsSource: nyt13 hr. 34 min. ago

The Wall Street Journal: Navarro report blasts China for systematic ‘economic aggression’

The release of the paper comes a day after President Donald Trump touched off a new phase of market turmoil by threatening expanded tariffs on Chinese imports.....»»

Category: topSource: marketwatch20 hr. 4 min. ago

Argenx"s phase 2 efgartigimod ITP data expected in September, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Idorsia (IDRSF) clazosentan Phase 3 trial update - Slideshow

Idorsia (IDRSF) clazosentan Phase 3 trial update - Slideshow.....»»

Category: topSource: seekingalphaJun 19th, 2018

Sarepta: DMD gene therapy shows 38.2% of micro-dystrophin in Phase 1/2a study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Sarepta DMD gene therapy shows 38% of micro-dystrophin in Phase 1/2a study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Sarepta shares rocket 55% on positive early results for DMD gene therapy

Sarepta Therapeutics Inc. shares rocketed 55.6% in extremely heavy Tuesday morning trade after the company reported positive early results from a phase 1/2a gene therapy clinical trial for three patients with the rare.....»»

Category: topSource: marketwatchJun 19th, 2018

Marinus initiates pivotal Phase 3 trial in children with CDKL5 CDD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

MediWound expands NexoBrid Phase 3 CIDS to U.S.

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Idera Stock Has Declined Since Failure Of Phase 2 Trial In Rare Disease, But That Wasn"t The Golden Ticket Indication

Idera Stock Has Declined Since Failure Of Phase 2 Trial In Rare Disease, But That Wasn"t The Golden Ticket Indication.....»»

Category: topSource: seekingalphaJun 19th, 2018

Sol-Gel Technologies initiates phase 3 program for Papulopustular Rosacea

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2018

KC Startup Foundation gets out of the coworking business

Kansas City's startup scene has evolved and the Kansas City Startup Foundation is evolving with it, stepping away from coworking and putting its building up for sale. KCSF's board of directors decided in May to phase out coworking from its mission,.....»»

Category: topSource: bizjournalsJun 18th, 2018